Esther F Schmid

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi request reprint Discovery, innovation and the cyclical nature of the pharmaceutical business
    Esther F Schmid
    Discovery Strategic Planning, Sandwich Laboratories, Pfizer Global R and D, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 7:563-8. 2002
  2. ncbi request reprint Should scientific innovation be managed?
    Esther F Schmid
    Discovery, Pfizer Sandwich Laboratories, IPC 475 Ramsgate Road, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 7:941-5. 2002
  3. ncbi request reprint Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
    Esther F Schmid
    Strategic Management, IPC 326, Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
    Drug Discov Today 12:998-1006. 2007
  4. ncbi request reprint Trust me--I'm a doctor!
    Esther F Schmid
    Research Strategic Planning, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 8:439-40. 2003
  5. doi request reprint Will biomedical innovation change the future of healthcare?
    Esther F Schmid
    Worldwide Medicinal Chemistry, Sandwich Laboratories, IPC 326, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
    Drug Discov Today 14:1037-44. 2009
  6. ncbi request reprint Communicating the risks and benefits of medicines
    Esther F Schmid
    Strategic Management, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Drug Discov Today 12:355-64. 2007
  7. ncbi request reprint Keynote review: Is declining innovation in the pharmaceutical industry a myth?
    Esther F Schmid
    Strategic Management Group, Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Drug Discov Today 10:1031-9. 2005
  8. ncbi request reprint R&D technology investments: misguided and expensive or a better way to discover medicines?
    Esther F Schmid
    Strategic Management Group, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, CT13 9NJ, UK
    Drug Discov Today 11:775-84. 2006
  9. doi request reprint Are predictive biomarkers of toxicity worth having? An economic model
    Byron Jones
    Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Xenobiotica 42:4-10. 2012
  10. ncbi request reprint Drug withdrawals and the lessons within
    Dennis A Smith
    Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, CT13 9NJ, UK
    Curr Opin Drug Discov Devel 9:38-46. 2006

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Discovery, innovation and the cyclical nature of the pharmaceutical business
    Esther F Schmid
    Discovery Strategic Planning, Sandwich Laboratories, Pfizer Global R and D, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 7:563-8. 2002
    ....
  2. ncbi request reprint Should scientific innovation be managed?
    Esther F Schmid
    Discovery, Pfizer Sandwich Laboratories, IPC 475 Ramsgate Road, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 7:941-5. 2002
  3. ncbi request reprint Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
    Esther F Schmid
    Strategic Management, IPC 326, Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
    Drug Discov Today 12:998-1006. 2007
    ..Occasionally, new therapies exacerbate the medical need gap, such as in cancer. Our paper discusses some of the reasons why this might be and why all of society needs to find solutions to address unmet medical need...
  4. ncbi request reprint Trust me--I'm a doctor!
    Esther F Schmid
    Research Strategic Planning, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 8:439-40. 2003
  5. doi request reprint Will biomedical innovation change the future of healthcare?
    Esther F Schmid
    Worldwide Medicinal Chemistry, Sandwich Laboratories, IPC 326, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
    Drug Discov Today 14:1037-44. 2009
    ..This paper presents several major forces which could drive different future scenarios including: R&D costs, the source of payments for medicines and the emergence of new modalities...
  6. ncbi request reprint Communicating the risks and benefits of medicines
    Esther F Schmid
    Strategic Management, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Drug Discov Today 12:355-64. 2007
    ..We analyse the role of major players, such as the media, patients, prescribers, regulators and pharmaceutical companies, and what actions are needed to better describe and communicate the risks and benefits of medicines to the public...
  7. ncbi request reprint Keynote review: Is declining innovation in the pharmaceutical industry a myth?
    Esther F Schmid
    Strategic Management Group, Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Drug Discov Today 10:1031-9. 2005
    ....
  8. ncbi request reprint R&D technology investments: misguided and expensive or a better way to discover medicines?
    Esther F Schmid
    Strategic Management Group, Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, CT13 9NJ, UK
    Drug Discov Today 11:775-84. 2006
    ....
  9. doi request reprint Are predictive biomarkers of toxicity worth having? An economic model
    Byron Jones
    Sandwich Laboratories, Pfizer Global Research and Development, Sandwich, Kent, UK
    Xenobiotica 42:4-10. 2012
    ..We present a model that takes these and other factors into account using data largely in line with real world cases...
  10. ncbi request reprint Drug withdrawals and the lessons within
    Dennis A Smith
    Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, CT13 9NJ, UK
    Curr Opin Drug Discov Devel 9:38-46. 2006
    ..This review classifies drugs withdrawn from the US market over the last 25 years by their reasons for withdrawal, and examines how drug discovery programs have been modified in response to these events...
  11. ncbi request reprint Is pharmaceutical R&D just a game of chance or can strategy make a difference?
    Esther F Schmid
    IPC 924, Sandwich Laboratories, PGRD, Ramsgate Road, Sandwich, Kent, UK CT13 9NJ
    Drug Discov Today 9:18-26. 2004
    ..Are these chance events, or have they come about through strategy? Here, we argue that a complex interplay of chance and strategy is at work in pharmaceutical R&D, separated in time by 10 years or more...